• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by AptarGroup Inc.

    3/27/26 8:09:34 AM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    DEFA14A 1 atr-20260327xdefa14a.htm DEFA14A

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of

    the Securities Exchange Act of 1934 (Amendment No.          )

    ​

    ​

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

    ☐

    Preliminary Proxy Statement

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

    Definitive Proxy Statement

    ☒

    Definitive Additional Materials

    ☐

    Soliciting Material under §240.14a-12

    Graphic

    ​

    ​

    ​

    ​

    AptarGroup, Inc.

    (Name of Registrant as Specified In Its Charter)

    ​

    ​

    ​

    ​

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    ​

    ​

    ​

    ​

    Payment of Filing Fee (Check all boxes that apply):

    ☒

    No fee required.

    ☐

    Fee paid previously with preliminary materials.

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

    ​

    ​


    GRAPHIC

    Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V89790-P47154-Z92167 *Please check the meeting materials for any special requirements for meeting attendance. APTARGROUP, INC. You invested in APTARGROUP, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on May 6, 2026. Vote Virtually at the Meeting* May 6, 2026 9:00 AM CDT Virtually at: www.virtualshareholdermeeting.com/ATR2026 Get informed before you vote View the Notice & Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 22, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. We encourage you to access and review all of the important information contained in the proxy materials before voting. APTARGROUP, INC. 265 EXCHANGE DRIVE SUITE 301 CRYSTAL LAKE, IL 60014 2026 Annual Meeting Vote by May 5, 2026 11:59 PM ET. For shares held in a Plan, vote by May 3, 2026 11:59 PM ET.

    GRAPHIC

    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V89791-P47154-Z92167 1. Election of Directors Nominees: 1a. George L. Fotiades For 1b. Candace Matthews For 1c. B. Craig Owens For 1d. Julie Xing For 2. Advisory vote to approve executive compensation. For 3. Ratification of the appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2026. For NOTE: THE PROXIES ARE AUTHORIZED TO VOTE IN THEIR DISCRETION UPON SUCH OTHER BUSINESS AS MAY PROPERLY BE BROUGHT BEFORE THIS MEETING. THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

    Get the next $ATR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    3/20/2026$144.00Equal Weight → Overweight
    Wells Fargo
    1/6/2026$133.00Overweight → Equal Weight
    Wells Fargo
    11/3/2025Outperform → Mkt Perform
    William Blair
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AptarGroup upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded AptarGroup from Equal Weight to Overweight and set a new price target of $144.00

    3/20/26 8:27:39 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded AptarGroup from Overweight to Equal Weight and set a new price target of $133.00

    1/6/26 8:44:42 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by William Blair

    William Blair downgraded AptarGroup from Outperform to Mkt Perform

    11/3/25 9:08:28 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tlili Hedi

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/20/26 2:24:51 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 4 filed by Kanu Vanessa

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/20/26 2:22:49 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 4 filed by Tanda Stephan B.

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/19/26 8:20:10 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    SEC Filings

    View All

    SEC Form DEFA14A filed by AptarGroup Inc.

    DEFA14A - APTARGROUP, INC. (0000896622) (Filer)

    3/27/26 8:09:34 AM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form DEF 14A filed by AptarGroup Inc.

    DEF 14A - APTARGROUP, INC. (0000896622) (Filer)

    3/27/26 8:08:53 AM ET
    $ATR
    Plastic Products
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by AptarGroup Inc.

    SCHEDULE 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    3/26/26 3:44:59 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

    Use of Aptar Pharma's UDS Powder system supports the development of a next‑generation, virus‑agnostic nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory infections AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its Unidose (UDS) Powder Nasal Spray System is being utilized in ENA Respiratory's Phase II clinical study of INNA 051, an investigational nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory infections. This collaboration reflects the growing role of intranasal delivery technologies

    3/19/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to reti

    3/17/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray

    Supporting advancement of complex intranasal therapies through clinical development AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited's (ASX:LTP) Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction. This milestone reflects Aptar Pharma's continued commitment to supporting intranasal drug delivery technologies and supporting the development of innovative, patient-centric therapies. This press release features multimedia. View the f

    3/16/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to reti

    3/17/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Reports Fourth Quarter and Annual 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205227722/en/Photo: Aptar Fourth Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth Reporte

    2/5/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026. As previously announced, Aptar will hold a conference call on Friday, February 6, 2026, at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed fo

    1/22/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces 2026 Quarterly Conference Call Dates

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release(1) Conference Call(2) 4th Quarter and Annual 2025 Results February 5, 2026 February 6, 2026, at 8:00 a.m. CT 1st Quarter 2026 Results April 30, 2026 May 1, 2026, at 8:00 a.m. CT 2nd Quarter 2026 Results July 30, 2026 July 31, 2026, at 8:00 a.m. CT 3rd Quarter 2026 Results

    1/7/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials